These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22198561)

  • 1. Use of toxicokinetics to support chemical evaluation: Informing high dose selection and study interpretation.
    Creton S; Saghir SA; Bartels MJ; Billington R; Bus JS; Davies W; Dent MP; Hawksworth GM; Parry S; Travis KZ
    Regul Toxicol Pharmacol; 2012 Mar; 62(2):241-7. PubMed ID: 22198561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of toxicokinetics to improve chemical risk assessment: implications for the use of animals.
    Creton S; Billington R; Davies W; Dent MP; Hawksworth GM; Parry S; Travis KZ
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):291-9. PubMed ID: 19665509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of diurnal systemic dose of agrochemicals in regulatory toxicity testing--an integrated approach without additional animal use.
    Saghir SA; Bartels MJ; Rick DL; McCoy AT; Rasoulpour RJ; Ellis-Hutchings RG; Sue Marty M; Terry C; Bailey JP; Billington R; Bus JS
    Regul Toxicol Pharmacol; 2012 Jul; 63(2):321-32. PubMed ID: 22440553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of ICH--toxicokinetics guidance and its practice--a useful approach for safety drug development].
    Tsuda M; Ohno Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):1-14. PubMed ID: 9641814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
    Dixit R; Riviere J; Krishnan K; Andersen ME
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proper knowledge on toxicokinetics improves human hazard testing and subsequent health risk characterisation. A case study approach.
    Bessems JG; Geraets L
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):325-34. PubMed ID: 24051162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
    Kimmel CA
    Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing a framework for integrating toxicokinetics into human health risk assessment for agrochemicals.
    Terry C; Hays S; McCoy AT; McFadden LG; Aggarwal M; Rasoulpour RJ; Juberg DR
    Regul Toxicol Pharmacol; 2016 Mar; 75():89-104. PubMed ID: 26472101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral test methods workshop.
    Slikker W; Acuff K; Boyes WK; Chelonis J; Crofton KM; Dearlove GE; Li A; Moser VC; Newland C; Rossi J; Schantz S; Sette W; Sheets L; Stanton M; Tyl S; Sobotka TJ
    Neurotoxicol Teratol; 2005; 27(3):417-27. PubMed ID: 15939202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products.
    Dekant W; Melching-Kollmuss S; Kalberlah F
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using toxicokinetic-toxicodynamic modeling as an acute risk assessment refinement approach in vertebrate ecological risk assessment.
    Ducrot V; Ashauer R; Bednarska AJ; Hinarejos S; Thorbek P; Weyman G
    Integr Environ Assess Manag; 2016 Jan; 12(1):32-45. PubMed ID: 25833822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of toxicokinetics in new drug development.
    Horii I
    Toxicol Lett; 1998 Dec; 102-103():657-64. PubMed ID: 10022331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food ingredient safety evaluation: Utility and relevance of toxicokinetic methods.
    Kabadi SV; Zang Y; Fisher JW; Smith N; Whiteside C; Aungst J
    Toxicol Appl Pharmacol; 2019 Nov; 382():114759. PubMed ID: 31521730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: a cross-company review.
    Sparrow SS; Robinson S; Bolam S; Bruce C; Danks A; Everett D; Fulcher S; Hill RE; Palmer H; Scott EW; Chapman KL
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):222-9. PubMed ID: 21855593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of in vitro data in risk assessment.
    Bernauer U; Oberemm A; Madle S; Gundert-Remy U
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):176-81. PubMed ID: 15733212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.